Data presented at the annual meeting of the American Urological Association shed light on the relationship between cholesterol and a man’s likelihood of developing prostate cancer.
More than 2,000 men were made subjects for the experiment. Each had been prescribed cholesterol-lowering drugs between 1990 and 2006. It was shown that their PSA levels, which can indicate the presence of prostate cancer, were lowered in proportion to their cholesterol. A similar study was conducted in 2007 with comparable results, confirming the fact that cholesterol may play a role in the development of prostate cancer.
The results of both studies show a definite link between cholesterol and PSA and can be used as reliable gauges for a man’s overall health.
Those interested in lowering their cholesterol levels may want to consider taking dietary supplements like those offered by Dr. Newton’s Naturals.
CholesterLite contains vital nutrients that help a body naturally regulate its own cholesterol. Regular use may promote cardiovascular health and lower “bad” cholesterol levels. It can be easily incorporated into a daily regiment without dramatically affecting one’s eating habits.